

NCT03196843 Raw comparison:

Summary:
CHIA has 13 criteria while your personal folder has 14 criteria
Total found criteria: 13/13
Total not Found: 0/13
Total Extra: 1
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ Before participate in the study patients must      │ Before participate in the study patients must      │
│ understand the treatment plan and willing to       │ understand the treatment plan and willing to       │
│ participate in the study Patients must have signed │ participate in the study Patients must have signed │
│ an approved informed consent                       │ an approved informed consent                       │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Histopathologic confirmed squamous cell carcinoma  │ Histopathologic confirmed squamous cell carcinoma  │
│ of head and neck including oral cavity oropharynx  │ of head and neck including oral cavity oropharynx  │
│ larynx or hypopharynx                              │ larynx or hypopharynx                              │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Ages=65 years Not limited to gender                │ Ages≥65 years Not limited to gender                │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ ECOG performance status =2                         │ ECOG performance status ≤2                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with surgical contraindication or reject  │ Patients with surgical contraindication or reject  │
│ to surgery                                         │ to surgery                                         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Postoperative TNM(primary tumor regional nodes     │ Postoperative TNM(primary tumor regional nodes     │
│ metastasis) staging III~IV positive surgical       │ metastasis) staging III\~IV positive surgical      │
│ margin                                             │ margin                                             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ without evidence of distant metastases             │ without evidence of distant metastases             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ No contraindication to chemoradiotherapy           │ No contraindication to chemoradiotherapy           │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Life expectancy > 3 months                         │ Life expectancy \> 3 months                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Available Organ function white blood cell=3        │ Available Organ function white blood cell≥3        │
│ 5×109/L Neutrophils =1 5×109/L Hemoglobin =80g/L   │ 5×109/L Neutrophils ≥1 5×109/L Hemoglobin ≥80g/L   │
│ Blood platelet>100×109/L Alanine aminotransferase  │ Blood platelet\>100×109/L Alanine aminotransferase │
│ (ALT) and Aspartate aminotransferase (AST)= 2 5    │ (ALT) and Aspartate aminotransferase (AST)≤ 2 5    │
│ upper limit of normal(ULN) Total bilirubin (TBIL)  │ upper limit of normal(ULN) Total bilirubin (TBIL)  │
│ <1 5 ULN serum creatinine=1 5 ULN creatinine       │ \<1 5 ULN serum creatinine≤1 5 ULN creatinine      │
│ clearance of = 50ml/min                            │ clearance of ≥ 50ml/min                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patients with a history of any other malignancy    │ Patients with a history of any other malignancy    │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Concomitant treatment with any other anticancer    │ Concomitant treatment with any other anticancer    │
│ therapy                                            │ therapy                                            │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Patient have contraindication to chemotherapy(eg   │ Patient have contraindication to chemotherapy(eg   │
│ uncontrolled coronarism and heart failure History  │ uncontrolled coronarism and heart failure History  │
│ of myocardial infarction within the past 6 months  │ of myocardial infarction within the past 6 months  │
│ Chronic obstructive pulmonary uncontrolled         │ Chronic obstructive pulmonary uncontrolled         │
│ epileptic attack and other disease that            │ epileptic attack and other disease that            │
│ investigator consider it unsuitable for the        │ investigator consider it unsuitable for the        │
│ chemotherapy)                                      │ chemotherapy)                                      │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have minimum age of 65 Years │
╘═══════════════════════════════════╛